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We previously reported that histamine induced mela-
nogenesis in cultured human melanocytes and that
the stimulatory effect was mediated by protein
kinase A activation via H2 receptors. It is well-
known that ultraviolet B irradiation causes acute
in¯ammation, known as erythema, and subsequent
pigmentation, and there are several reports demon-
strating an elevation of the histamine levels in ultra-
violet B-irradiated skin. Thus, to evaluate the
involvement of histamine in ultraviolet B-induced
skin pigmentation, we examined the effect of an H2
antagonist in brownish guinea pig skin. Daily expos-
ure to 200 mJ per cm2 ultraviolet B for 3 d evoked
erythema and subsequent pigmentation in the skin
samples tested. Moreover, a remarkable increase in
dopa-positive melanocytes was observed in the pig-
mented area, which showed an increase in melanin
synthesis. Topical application of famotidine, an H2
antagonist, signi®cantly reduced pigmentation and
moderated the increase of dopa-positive melanocytes
in the ultraviolet B-irradiated skin. Even when the
initiation of famotidine application was delayed to
day 2 after irradiation, an inhibitory activity on
ultraviolet B-induced pigmentation was observed;
however, the ultraviolet B-induced erythema was not
suppressed by topically applied famotidine. Thus, we
concluded that histamine is involved in ultraviolet B-
induced pigmentation and that famotidine sup-
pressed the pigmentation by the prevention of hista-
mine binding to H2 receptors in melanocytes but not
by prevention of ultraviolet B permeability and
in¯ammation. Key words: erythema/famotidine/in¯am-
mation/melanogenesis. J Invest Dermatol 118:255±260,
2002
U
ltraviolet (UV) B-induced in¯ammation often
evokes delayed pigmentation (Prunieras, 1986).
The in¯ammation involves erythema, which
peaks at 6 h after UV irradiation and persists
for 24±48 h in human skin and guinea pig skin
(Whitman et al, 1985; Fitzpatrick, 1986; Diffey and Oakley,
1987). Pigmentation is observed in the irradiated regions
approximately 1 wk after UV irradiation and its intensity
parallels the severity of erythema. As the suppression of
erythema leads to a decrease of pigmentation (Takiwaki et al,
1994), it was considered that in¯ammatory factors such as
prostanoids and eicosanoids play an important part in triggering
melanin synthesis in UV-induced pigmentation (Nordlund and
Askenase, 1983; Tomita et al, 1992; Morelli and Norris, 1993),
as well as other melanogens such as endothelin-1 (Imokawa et
al, 1995) and a-melanocyte-stimulating hormone (Hunt et al,
1994). Our group previously demonstrated that histamine, a
ubiquitous in¯ammatory factor, has a melanogenic effect on
human cultured melanocytes (Tomita et al, 1988, 1993). The
stimulation of histamine was mediated by H2 receptors (Yoshida
et al, 2000). In human skin, histamine is produced and released
by dermal mast cells and keratinocytes, and an elevation of
histamine release by UV irradiation was reported by Gilchrest
et al (1981) and Malaviya et al (1996). These ®ndings strongly
suggested the involvement of histamine in UV-stimulated pig-
mentation; however, Iwata et al (1990) reported that histamine had
no melanogenic effect on a human foreskin culture, and that the
abundant release of histamine in vivo did not always lead to
pigmentation in the skin. Thus, the involvement of histamine in skin
pigmentation remains obscure. In this study, we attempted to
elucidate the involvement of histamine in UV-induced skin
pigmentation by examining the effect of topically applied H2
antagonist on UV-induced pigmentation. We used brownish guinea
pig skin to investigate the effect of H2 antagonist, as it was reported
that guinea pig skin serves as an excellent pigmentation model
resembling human skin (Imokawa et al, 1986; Imokawa and Kawai,
1987; Bolognia et al, 1990).
MATERIALS AND METHODS
Materials Human melanocytes and bovine pituitary extracts were
purchased from Kurabo (Osaka, Japan). MCDB153 medium, bovine
insulin, dihydroxy-phenylalanine (dopa), trichloroacetic acid, and
propylene glycol were obtained from Wako Pure Chemical Industries
(Osaka, Japan). Hydrocortisone was purchased from Merck (Whitehouse
Station, NJ). Basic ®broblast growth factor was purchased from Intergen
Company (New York). Phorbol 12-myristate 13-acetate, melanin,
epidermal growth factor, ranitidine, and famotidine were purchased from
Sigma-Aldrich Corporation (St Louis, MO). [3H]-tyrosine was purchased
from Amersham Pharmacia Biotech (Uppsala, Sweden). Charcoal was
obtained from Kanto Chemical (Tokyo, Japan).
Animals A-1 and Hartley strain guinea pigs were purchased from SLC
(Tokyo, Japan).
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Methods
Melanocyte culture Human melanocytes were maintained in modi®ed
MCDB 153 supplemented with 1 ng per ml recombinant human basic
®broblast growth factor, 5 mg insulin per ml, 500 ng hydrocortisone per
ml, and 10 ng phorbol 12-myristate 13-acetate per ml according to the
method of Yada et al (1991). The cells were incubated in MGM
consisting of modi®ed MCDB 153 supplemented with 1 ng recombinant
human basic ®broblast growth factor per ml, 5 mg insulin per ml, and
5 mg puri®ed mouse epidermal growth factor per ml for at least 3 d
before the experiment.
Tyrosinase assay To determine the tyrosinase activity of the cells, the
activity of tyrosine hydroxylation was measured using the following
method (Imokawa et al, 1995). Melanocytes were seeded in 12-well
culture trays at a density of 1.2 3 105 cells per well and cultured. After
incubation in MGM for 3 d, the cells were treated with histamine or
another reagent for 60 h. During the last 36 h of treatment, the cells
were incubated with 1.0 mCi per ml [3H]-tyrosine. Next, 700 ml of 10%
trichloroacetic acid containing 20% charcoal (charcoal solution) was
added to the medium (700 ml), the mixture was mixed in a vortex for
30 s, and then centrifuged at 12,000 3 g with an MRX-150 centrifuge
(Tomy Seiko, Tokyo, Japan) for 10 min. Seven hundred microliters of
the supernatant were transferred into a new tube and treated twice with
the charcoal solution. The radioactivity of the ®nal supernatant was
determined in a liquid scintillation counter (LSC1000, Aloka, Tokyo,
Japan).
Experimental animals and UV irradiation Five female A-1 strain guinea pigs
were used in the pigmentation study. The guinea pigs were housed in
solid bottom metal cages that contained pine shavings and fed standard
guinea pig chow. The temperature was maintained between 24 and
26°C. Hair was shaved from the dorsal skin of the guinea pigs with an
electric shaver, and two or four slots were arranged on the exposed skin.
The dorsal skin was exposed to UVB irradiation at 200 mJ per cm2
(minimal erythema dose for an A-1 guinea pig) per day for 3 d with a
bank of FL-32S/E-30DMR lamps (UVB range: 290±330 nm, peak at
305 nm, Toshiba Medical, Tokyo, Japan) to induce pigmentation. The
radiation dosage was measured with a UV Radiometer (UVR-305/
365DII, Topcom, Tokyo, Japan). Famotidine was added to a vehicle of
25% ethanol, 25% propyleneglycol, and 50% water. Famotidine
treatment for the pigmentation experiment was performed as follows:
One hundred microliter aliquots of the vehicle or a 2% solution of
famotidine in the vehicle were applied to allotted regions of exposed
animal skin. The application was initiated at 1 d before irradiation and
performed twice per day in the morning and the evening for 2 wk after
irradiation. UV irradiation was performed at least 12 h after famotidine
treatment.
On the day of UV irradiation, we ®rst performed the irradiation in
the early morning, and then immediately applied famotidine. The second
application of famotidine was performed 10 h after the ®rst application.
To examine the effect of famotidine on UV-induced erythema, the
dorsal skin of female Hartley strain guinea pigs was exposed to UV
irradiation once at 200 or 300 mJ per cm2 and then immediately treated
with a 100 ml aliquot of vehicle or a 2% solution of famotidine. We
found that 200 mJ per cm2 was the average minimal erythema dose for
Hartley strain guinea pigs, and that 200±600 mJ per cm2 is the range of
UVB dose that had a linear relationship between UVB dose and severity
of erythema score (data not shown).
Measurement of degree of pigmentation and erythema The skin luminosity of
each region was measured using a Chromo Meter (CR-300, Minolta,
Tokyo, Japan). Chromaticity was evaluated using three indices designated
as the L*, a*, and b* values, matching the Commission Internationale de
l'Eclairage standard observer response. The L* and a* values of each
guinea pig were determined by averaging the data of ®ve ®elds.
The effects of famotidine were evaluated using the L* and a* values as
indices (Nose and Tsurumi, 1993; Maeda and Naganuma, 1998).
Histochemical procedures Skin specimens were removed from the UV-
exposed areas of each guinea pig and six specimens per treatment were
compared using the method of Imokawa et al (1986). The tissues were
rinsed with 0.1 M phosphate-buffered saline and incubated in 1 M
sodium borate at 37°C for 5 h. Epidermal sheets separated from the
dermis were ®xed in 10% neutral buffered formalin for 30 min, washed
twice with phosphate-buffered saline and incubated in 0.1%
dihydroxyphenylalanine (dopa) in phosphate-buffered saline for 5 h. The
number of dopa-positive melanocytes in each specimen was counted and
determined by averaging the counts in ®ve ®elds.
Statistical analysis A probability level of p < 0.05 was considered
signi®cant when results were subjected to a paired t test or Dunnet's
comparison.
RESULTS
Effect of H2 antagonist on histamine-induced
melanogenesis in cultured human melanocytes As
previously reported, histamine induces melanogenesis via H2
receptors. Histamine (1 mM) changed the morphology of human
melanocytes into an activated form and caused tyrosinase activation
(compare Fig 1b with Fig 1a). Two types of H2 antagonists,
Figure 1. Effect of H2 antagonists on
morphologic changes induced by histamine.
Human melanocytes were cultured for 72 h in the
presence of vehicle (a), 1 mM histamine (b), 1 mM
histamine with 1 mM famotidine (c), or 1 mM
histamine with 10 mM ranitidine (d). Scale bar:
50 mm.
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famotidine and ranitidine, completely suppressed the histamine-
induced morphologic changes (compare Fig 1c, d with Fig 1b) and
tyrosinase activation (Fig 2A, B). Moreover, the suppressive effects
of these two reagents on tyrosinase activity were not observed in
melanocytes not treated with histamine (Fig 2A, B). Taking the
above ®ndings together, we concluded that the melanogenic action
of histamine is mediated by H2 receptors in human melanocytes.
Next, we examined the effect of famotidine on UV-induced
pigmentation to evaluate histamine involvement in vivo.
Suppression of UVB-irradiated pigmentation by famotidine
in guinea pigs Erythema was noted in all UVB-irradiated
regions of A-1 strain guinea pigs for several days after irradiation.
We ®rst noticed that all guinea pigs developed pigmentation 1 wk
after irradiation in the same regions in which erythema occurred.
Two weeks after irradiation, skin darkening completely reached a
plateau level and was quanti®ed by measuring the luminance (L*)
value expressing relative brightness from black to white. Topical
application of 2% famotidine prevented L* value reduction by 40%
in the UVB-induced pigmentation areas 2 wk after irradiation
(Fig 3A). These decreases in the L* value as well as increases of
dopa-positive melanocytes in the region were also suppressed by
famotidine (Fig 3B, C).
Late application of famotidine after UVB irradiation was
also effective in suppressing pigmentation The UVB
absorption of famotidine solution peaked at 290 nm. To avoid
the UV ®lter effect of famotidine, we initiated famotidine
application 48 h after the ®nal UVB irradiation. In this case,
famotidine also suppressed the UV-induced decrease of skin
luminosity (Fig 4A) as well as the increase of the number of
dopa-positive melanocytes (Fig 4B). Thus, we were able to show
here that famotidine suppresses pigmentation in an H2 receptor-
mediated manner; however, we could not rule out the possibility
that famotidine partially acted as a UV ®lter in the former
experiment as the suppressive activity in this experiment was
weaker than that in the former. Moreover, these data suggested that
the histamine action persisted longer than 48 h after irradiation,
although it has been reported that histamine release returned to the
basal level 4 h after irradiation in human skin (Gilchrest et al, 1981).
Famotidine did not suppress UVB-induced erythema To
rule out the possibility that famotidine suppresses pigmentation by
prevention of in¯ammation induction, we compared the erythema
index between the vehicle- and famotidine-applied regions.
Erythema was induced by UVB irradiation at both 200 and
300 mJ per cm2 and was detected after 1 h in Hartley-strain albino
guinea pig skin. The a* value, which represents color hues ranging
from yellow to red, was measured at 3, 6, and 24 h after irradiation.
UVB-induced erythema peaked at 6 h and mostly disappeared after
24 h (Fig 5A, B). The erythema indices were not affected by
famotidine treatment with either dose of UVB in any of the
measurements. These results suggest that famotidine has no
inhibitory effect on UVB-induced in¯ammation as has been
reported for other H2 antagonists by Akter et al (1998).
DISCUSSION
We previously showed that histamine, a ubiquitous in¯ammatory
factor, has a melanogenic effect on human cultured melanocytes via
H2 receptors. In this study, we further demonstrated that two types
of H2 antagonists, famotidine and ranitidine, inhibited the increase
in tyrosinase activity by histamine in a concentration-dependent
manner. The difference in concentration dependence of the
inhibitory effect between famotidine and ranitidine must be due
to the different pA2 values (7.8 and 7.2, respectively; Leurs et al,
1995). The pA2 value is used as an empirical measure of the activity
of an antagonist and is the negative logarithm of the concentration
of the antagonist that causes a reduction of histamine ef®cacy to the
same extent as a half concentration.
We found that a topically applied H2 antagonist suppressed
pigmentation by reducing the increase of activated melanocytes by
UVB irradiation. We eliminated the possibility that the H2
antagonist suppressed the pigmentation only via a shielding ability
against UVB by showing that it was also effective when the
treatment was initiated after irradiation. Further, it did not act by a
suppression of erythema, because the reagent did not have an effect
on the erythema induction. Thus, we concluded that histamine is
involved in UVB-induced pigmentation by an H2 receptor-
mediated activation of melanocytes. We considered that this
pathway plays a limited part in the pigmentation induced by UVB,
however, as the H2 antagonist was only able to reduce the increased
number of DOPA-positive melanocytes by 30% (Figs 3C and 4C).
We speculated that the remaining portion of UVB-evoked
Figure 2. Effect of H2 antagonists on the tyrosinase activation by
histamine. Human melanocytes were stimulated by 1 mM histamine
(open column) or none (solid column) for 60 h in the presence of various
concentrations of ranitidine (A) and famotidine (B). The cells were
incubated with 1.0 mCi per ml (3H)-tyrosine for the last 36 h.
Tyrosinase activity was determined as 3H2O release into culture media as
described in Materials and Methods. Each value of tyrosinase activity is the
mean 6 SEM of three determinations. *p < 0.05 and **p < 0.01 as
compared with the control by Dunnett's test.
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Figure 4. Effect of famotidine applied after UVB irradiation on the irradiated A-1 guinea pig skin. Experiments were carried out in the
same manner as those shown in Fig 3 except that famotidine application started at 48 h after ®nal UVB irradiation. (A) Each L* value of the test site
treated with vehicle (d) or 2% famotidine (s) was determined as above. Each L* value is the mean 6 SEM of six determinations. (B) The number of
dopa-positive melanocytes in each skin specimen was determined as described above. Each melanocyte count is the mean 6 SEM of three
determinations. **p < 0.01 and *p < 0.05 as compared with the control by the paired t test.
Figure 3. Effect of famotidine on the UVB-
induced pigmentation in A-1 guinea pig skin. (A)
Brownish guinea pig skin observed at 14 d after ®nal
UVB irradiation. Test sites are the vehicle-treated area
(a) and the 2% famotidine-treated area (b). Application
started at 1 d before UVB irradiation as described in
Materials and Methods. (B)Skin luminosity index (L*) of
the test site treated with vehicle (d) or 2% famotidine
(s) was determined by averaging the measurement in
®ve ®elds with the Chroma Meter (Minolta CR-300)
as described in Materials and Methods. Each value of L*
is the mean 6 SEM of six animals. (C) The number of
dopa-positive melanocytes in each specimen of the
tested sites was determined by averaging the cell counts
in ®ve ®elds. Melanocyte count is the mean 6 SEM of
three specimens. **p < 0.01 as compared with the
control by the paired t test.
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pigmentation may be induced by other factors, such as prostaglan-
dins, a-melanocyte-stimulating hormone, endothelin-1, or nitric
oxide (Romero-Graillet et al, 1996, 1997; Brown et al, 1999).
From the results of a report in which the intensity of
pigmentation paralleled the severity of erythema (Takiwaki et al,
1994), it is easy to speculate that both erythema and pigmentation
are regulated by the same mechanism; however, our data showed
that UVB-induced pigmentation was partly blocked by H2
antagonists whereas erythema induction was not. Thus, erythema
and pigmentation may be regulated by different mechanisms. We
also showed that erythema induction could not possibly be
mediated through H2 receptors; however, we could not exclude
the involvement of other histamine receptors in the induction of
erythema, as several studies have shown that histamine affects the
secretion of other in¯ammatory factors, such as prostaglandins and
nitric oxide, via H1 receptors in the skin (Hruza and Pentland,
1993; Gimeno et al, 1998; Clough, 1999). Accordingly, we are
now examining the involvement of histamine in erythema
induction via H1 receptors.
Abundant and prolonged release of histamine in vivo seems to be
required to induce pigmentation in human skin, because recurrent
urticaria does not evoke pigmentation, whereas urticaria pigmen-
tosa does. The skin lesions of urticaria pigmentosa contain a large
amount of mast cells with high levels of histamine (25±590 mg of
histamine per g of tissue) (Graneous et al, 1983), whereas the
number of mast cells is not changed in the skin of recurrent
urticaria and the concentration of histamine in the subcutaneous
perfusates recovered from dermographic skin has been reported to
be 5±29.5 ng per ml (Sondergaard and Greaves, 1970). We also
observed that repeated applications of high concentrations of
histamine induced ¯are but not pigmentation in guinea pig skin
(data not shown). Various factors, such as arachidonate derivatives
(Tomita et al, 1992), a-melanocyte-stimulating hormone (Hunt et
al, 1994), endothelin-1 (Imokawa et al, 1995), basic ®broblast
growth factor (Yaar and Gilchrest, 1991), and nitric oxide
(Romero-Graillet et al, 1996), have been reported to be pigmen-
tation inducers apart from histamine in UVB-irradiated skin;
however, from the results of this study we cannot exclude the
Figure 5 Effect of famotidine application on UVB-induced
erythema in Hartley guinea pigs. UVB irradiation and famotidine
application were carried out as described in Materials and Methods. (A)
Albino guinea pig skin observed at 6 h after UVB irradiation. Test sites
were treated with the vehicle and 200 mJ per cm2 UVB (a), 2%
famotidine and 200 mJ per cm2 UVB (b), the vehicle and 300 mJ per
cm2 UVB (c), and 2% famotidine and 300 mJ per cm2 UVB (d). (B)
Erythema indices (a*) of the test site treated with vehicle (d) or 2%
famotidine (s) at 200 mJ per cm2 UVB, and vehicle (j) or 2%
famotidine (h) at 300 mJ per cm2 were determined by averaging the
measurements from ®ve ®elds with a Chroma Meter (Minolta CR-300),
as described in Materials and Methods. Each a* value is the mean 6 SEM
of 10 animals.
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possibility that histamine release alone may not be a suf®cient cause
of pigmentation in vivo. We considered that the observed
pigmentation was evoked as a result of the total effect of these
factors along with histamine, and that histamine alone may be
insuf®cient (Iwata et al, 1990). We are now focusing on the
cooperation between histamine and other factors in melanogenesis
induction.
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